SG Talk
FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 to 17 - Printable Version

+- SG Talk (https://sgtalk.net)
+-- Forum: SG Talk (https://sgtalk.net/Forum-SG-Talk)
+--- Forum: Market Talk (https://sgtalk.net/Forum-Market-Talk)
+--- Thread: FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 to 17 (/Thread-FDA-authorizes-emergency-use-for-Novavax-Covid-19-vaccine-for-ages-12-to-17)



FDA authorizes emergency use for Novavax Covid-19 vaccine for ages 12 to 17 - theold - 21-08-2022

Two doses of the Novavax vaccine were 90% effective at preventing illness from Covid across the board and 100% effective at preventing severe illness, according to clinical trial data from the U.S. and Mexico. 

However, the trial was conducted from December 2020 through September 2021, months before the omicron variant became dominant.

Novavax published data in December showing that a third shot boosted the immune response to levels comparable to the first two doses which had 90% effectiveness against illness. The company plans to ask the FDA to authorize a third dose of its vaccine.

https://www.cnbc.com/2022/08/20/fda-authorizes-emergency-use-for-novavax-covid-19-vaccine-for-ages-12-and-17-.html